New alopecia drug regrows hair in 40% of patients -- FDA approval sought - New York Post

The latest trial studied 706 adults who have alopecia, aged 18 to 65, for 24 weeks in the US, Canada and Europe.

They’re making gains in the hair-loss industry. Researchers have discovered a drug to potentially solve alopecia, a condition that causes hair loss. United States drug company Concert Pharmaceutica… [+3372 chars]

full article...